Immunotherapy in Breast Cancer:

Immunotherapy is a new way to fight breast cancer by helping the body's immune system identify and destroy cancer cells. This approach is especially promising for aggressive types of breast cancer like triple-negative and HER2-positive cancers. Immunotherapy treatments include:

  1. Checkpoint inhibitors: Drugs that help the immune system recognize and attack cancer cells more effectively.
  2. Monoclonal antibodies: Targeted therapies that can mark cancer cells for the immune system to find and destroy.
  3. Cancer vaccines: Aim to prevent cancer from coming back by training the immune system to fight cancer cells.
  4. CAR T-cell therapy: A treatment that enhances the patient's own immune cells to better fight cancer.

These treatments offer new hope, especially for breast cancer that's hard to treat with traditional methods. Research is ongoing to find the best ways to use immunotherapy, alone or with other treatments, to improve outcomes for breast cancer patients.

    Related Conference of Immunotherapy in Breast Cancer:

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Immunotherapy in Breast Cancer: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in